Vaccines & Disease · Hepatitis A

Hepatitis A Disease & Vaccine Information

Below are brief introductions to Hepatitis A disease and the Hepatitis A vaccine with links to more information. Scroll down for a list of QUICK FACTS that provide a summary overview of key facts for the disease and the vaccine.

Published October 12, 2021
The Disease

Hepatitis A: The Disease

Hepatitis A is viral disease of the liver caused by the hepatitis A virus (HAV). Humans are the only natural host of this virus.1 The hepatitis A virus is very stable and can remain present for several months in most environments. The virus, however, can be killed by high temperatures (temperatures greater than 85C/185F), or by solutions such as chlorine, or formalin.23 Hepatitis A is contracted orally and typically acquired by coming into contact with human fecal waste, generally through the consumption of contaminated food and/or water.4 Source of contamination may include raw shellfish, fruits and vegetables and ice.5

An infected individual can spread hepatitis A to others for one to two weeks prior to becoming symptomatic.67 It generally takes an average of four weeks (range of two to seven weeks) following exposure to hepatitis A for symptoms to develop. Symptoms often occur suddenly and include fatigue, abdominal and/or joint pain, loss of appetite, fever, nausea, jaundice, dark urine, clay-colored bowel movements, and diarrhea. Young children are often asymptomatic and show no clinical signs of infection.8 Most infected individuals recover fully within 2 months, however, approximately 10 to 15 percent of infected individuals can have lingering symptoms for up to 6 months.9

The Vaccine

Hepatitis A Vaccine

The U.S. Food and Drug Administration and U.S. Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control (CDC) has approved three different hepatitis A containing shots. There are different rules for use of these vaccines by different aged groups. The CDC’s Advisory Committee on Immunization Practices currently recommends that all children receive the first dose of hepatitis A vaccine between 12 and 23 months of age and the second dose is recommended 6 months or longer following the first dose of the vaccine. Additionally, hepatitis A vaccination is recommended for person considered at high risk for developing hepatitis A related to travel, employment, pre-existing health issues, lifestyle and in the event of an outbreak situation.10

Quick Facts

Hepatitis A at a glance

Hepatitis A Quick Facts

  1. Hepatitis A is a viral disease of the liver that is contracted through contact with, or by swallowing human fecal waste, generally through eating or drinking contaminated food and/or water.11 The virus is typically spread when people eat or drink something that has been contaminated with the virus.12
  2. Symptoms of hepatitis A generally appear between two and seven weeks following exposure to the virus and infected individuals can spread the virus to others for up to two weeks before showing symptoms.13 Symptoms often occur suddenly and may include fatigue, abdominal and/or joint pain, loss of appetite, fever, nausea, jaundice, dark urine, clay-colored bowel movements, and diarrhea. Younger children often show no clinical symptoms of infection. Only lab testing can confirm a diagnosis of hepatitis A.14

Hepatitis A Vaccine Quick Facts

  1. There are three hepatitis A containing vaccines available for use in the United States. VAQTA,15 an inactivated hepatitis A virus vaccine, manufactured by Merck; HAVRIX,16 an inactivated hepatitis A virus vaccine manufactured by GlaxoSmithKline; and TWINRIX,17 a combination vaccine containing both inactivated hepatitis A virus vaccine (HAVRIX) and recombinant hepatitis B vaccine (ENGERIX-B), manufactured by GlaxoSmithKline. VAQTA, HAVRIX, and TWINRIX were developed using aborted fetal cells.181920
  2. Using the MedAlerts search engine, as of January 2, 2026, there have been 54,467 reports of hepatitis A vaccine reactions, hospitalizations, injuries and deaths following hepatitis A vaccinations made to the federal Vaccine Adverse Events Reporting System (VAERS), including 196 related deaths, 3,860 hospitalizations, and 1,051 related disabilities.
References
  1. 1Communication and Education Branch, National Center for Immunization and Respiratory Diseases (NCIRD) and the Centers for Disease Control (CDC). Hepatitis A. Centers for Disease Control (CDC) Aug. 18, 2021.
  2. 2US Centers for Disease Control and Prevention. How is the hepatitis A virus (HAV) killed?. July 28, 2020.
  3. 3Communication and Education Branch, National Center for Immunization and Respiratory Diseases (NCIRD) and the Centers for Disease Control (CDC). Hepatitis A. Centers for Disease Control (CDC) Aug. 18, 2021.
  4. 4US National Library of Medicine MedlinePlus. Hepatitis A. Jan. 11, 2021.
  5. 5WebMD. Hepatitis A (Hep A). Dec. 5, 2021.
  6. 6WebMD. Hepatitis A (Hep A). Dec. 5, 2021.
  7. 7Communication and Education Branch, National Center for Immunization and Respiratory Diseases (NCIRD) and the Centers for Disease Control (CDC). Hepatitis A. Centers for Disease Control (CDC) Aug. 18, 2021.
  8. 8US Centers for Disease Control and Prevention. What are the symptoms of hepatitis A. July 28, 2020.
  9. 9Communication and Education Branch, National Center for Immunization and Respiratory Diseases (NCIRD) and the Centers for Disease Control (CDC). Hepatitis A. Centers for Disease Control (CDC) Aug. 18, 2021.
  10. 10Fiore AE, Wasley A, Bell BP. Prevention of Hepatitis A Through Active or Passive Immunization Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR May 19, 2006.
  11. 11US National Library of Medicine MedlinePlus. Hepatitis A. Jan. 11, 2021.
  12. 12WebMD. Hepatitis A (Hep A). Dec. 5, 2021.
  13. 13US Centers for Disease Control and Prevention. What are the symptoms of hepatitis A. July 28, 2020.
  14. 14Communication and Education Branch, National Center for Immunization and Respiratory Diseases (NCIRD) and the Centers for Disease Control (CDC). Hepatitis A. Centers for Disease Control (CDC) Aug. 18, 2021.
  15. 15Merck Sharp & Dohme Corp. Package Insert – VAQTA. U.S. Food and Drug Administration Oct. 26, 2020.
  16. 16GlaxoSmithKline Biologicals. Package Insert – Havrix. U.S. Food and Drug Administration Dec. 6, 2021.
  17. 17GlaxoSmithKline Biologicals. Package Insert – TWINRIX. U.S. Food and Drug Administration Oct. 3, 2019.
  18. 18Merck Sharp & Dohme Corp. Package Insert – VAQTA. U.S. Food and Drug Administration Oct. 26, 2020.
  19. 19GlaxoSmithKline Biologicals. Package Insert – Havrix. U.S. Food and Drug Administration Dec. 6, 2021.
  20. 20GlaxoSmithKline Biologicals. Package Insert – TWINRIX. U.S. Food and Drug Administration Oct. 3, 2019.
Select disease / vaccine